Shares of Cepheid rose 7.5 percent for the five-day trading period ended Tuesday. The trading week was cut short a few hours on Tuesday in advance of the Independence Day holiday in the US.
 
Cepheid and Becton Dickinson were mentioned in an article in Friday’s edition of The Wall Street Journal focused on new testing methods for antibiotic resistance in hospitals. The firms make the only Food and Drug Administration-cleared molecular-based tests for methicillin-resistant Streptococcus aureus.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.